Press Releases
January 7, 2021
TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical TrialDecember 15, 2020
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical Trial
TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare ConferenceNovember 12, 2020
TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business ResultsNovember 5, 2020
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License AgreementNovember 5, 2020
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody TherapiesNovember 2, 2020
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020October 28, 2020
TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza VaccinesOctober 27, 2020
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with ExpericOctober 26, 2020
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation PowderOctober 20, 2020
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder